Disease outcomes in a cohort of women in Ireland infected by hepatitis C-contaminated anti-D immunoglobulin during 1970s.

[1]  Douglas L. Nguyen,et al.  Chronic Hepatitis C Virus Infection: A Review of Current Direct-Acting Antiviral Treatment Strategies. , 2016, North American journal of medicine & science.

[2]  G. Dusheiko,et al.  Natural history of hepatitis C. , 2014, Journal of hepatology.

[3]  T. Berg,et al.  Evaluation of liver disease progression in the German hepatitis C virus (1b)‐contaminated anti‐D cohort at 35 years after infection , 2014, Hepatology.

[4]  M. Zwahlen,et al.  Little evidence that hepatitis C virus leads to a higher risk of mortality in the absence of cirrhosis and excess alcohol intake: the Swiss Hepatitis C Cohort Study , 2009, Journal of viral hepatitis.

[5]  L. Seeff.  The history of the “natural history” of hepatitis C (1968–2009) , 2009, Liver international : official journal of the International Association for the Study of the Liver.

[6]  G. Alexander,et al.  Does the clinical outcome of hepatitis C infection vary with the infecting hepatitis C virus type? , 2007, Journal of viral hepatitis.

[7]  Mark Wright,et al.  Estimated progression rates in three United Kingdom hepatitis C cohorts differed according to method of recruitment. , 2006, Journal of clinical epidemiology.

[8]  N. Andrews,et al.  Survival of a national cohort of hepatitis C virus infected patients, 16 years after exposure , 2005, Epidemiology and Infection.

[9]  A. Zanetti,et al.  Long‐term outcome (35 years) of hepatitis C after acquisition of infection through mini transfusions of blood given at birth , 2004, Hepatology.

[10]  M. Yuen,et al.  Viral hepatitis C , 2003, The Lancet.

[11]  K. Ishak,et al.  Long‐term mortality and morbidity of transfusion‐associated non‐A, non‐B, and type C hepatitis: A National Heart, Lung, and Blood Institute collaborative study , 2001, Hepatology.

[12]  C. Sabin,et al.  The natural history of HCV in a cohort of haemophilic patients infected between 1961 and 1985 , 2000, Gut.

[13]  E. Kenny‐Walsh.  Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group. , 1999, The New England journal of medicine.

[14]  J. Ludwig,et al.  The long‐term pathological evolution of chronic hepatitis C , 1996, Hepatology.

[15]  M. Tong,et al.  Clinical outcomes after transfusion-associated hepatitis C. , 1995, The New England journal of medicine.

[16]  S. Gordon,et al.  The pathology of hepatitis C as a function of mode of transmission: Blood transfusion vs. Intravenous drug use , 1993, Hepatology.

[17]  R. Purcell,et al.  Interrelationship of blood transfusion, non‐A, non‐B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus , 1990, Hepatology.